USA based Pendulum develops next generation probiotics that target the gut microbiome to improve metabolic and digestive human health, starting with the most pressing challenges of our time: diabetes, metabolic disorders, and gut dysfunction. The company specializes in creating specific formulations that feature the unique and live bacterial strain Akeermansia muciniphila, which Pendulum was the first to stabilize and sell as a consumer product.
